Sign Out
Epirubicin hydrochloride is used in the treatment of a range of neoplastic conditions including: Carcinoma of the breast; Gastric cancer.
When administered intravesically, epirubicin hydrochloride has been shown to be beneficial in the treatment of: Papillary transitional cell carcinoma of the bladder; Carcinoma-in-situ of the bladder; lntravesical prophylaxis of recurrences of superficial bladder carcinoma following transurethral resection.
